Maintainence Treatment of Opioid Dependence with Tramadol

ABSTRACT Background: Although tramadol has been used in the management of acute withdrawal in patients with opioid dependence, its use for maintenance treatment as a harm reduction approach has not been assessed systematically. This case series describes patients with opioid dependence who were treated with tramadol for long-term maintenance. Methods: Patients with opioid dependence who received treatment at the National Drug Dependence Treatment Centre of All India Institute of Medical Sciences, New Delhi, were included in the study. Patients who received at least 6 months of tramadol and had follow-up adherence of more than 80% were included in the case series. Results: A total of 25 cases were included, all of whom were males. The types of opioids being taken at the time of initiation of tramadol were natural opiates (poppy husk and raw opium), followed by heroin. The median dose of tramadol at initiation and maintenance was 300 mg/day. Nineteen patients were able to achieve complete abstinence to other opiates on tramadol. Conclusion: Tramadol may be an effective option in the long-term management of patients with opioid dependence. Further studies are required for establishing the efficacy of tramadol for agonist management of patients with opioid dependence.

[1]  M. Farrell,et al.  Response to commentaries on 'Which medications are suitable for agonist drug maintenance'. , 2016, Addiction.

[2]  P. Mandal,et al.  Tramadol: a good option for management of opioid withdrawal syndrome in developing countries , 2015 .

[3]  Björn Johnson,et al.  Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors. , 2015, The International journal on drug policy.

[4]  G. Paré,et al.  The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol , 2014, Systematic Reviews.

[5]  S. Walsh,et al.  A Review of Buprenorphine Diversion and Misuse: The Current Evidence Base and Experiences From Around the World , 2014, Journal of addiction medicine.

[6]  S. Walsh,et al.  Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial. , 2013, Drug and alcohol dependence.

[7]  A. Ambekar,et al.  Delivery models of opioid agonist maintenance treatment in South Asia: a good beginning. , 2013, Bulletin of the World Health Organization.

[8]  N. Nebhinani,et al.  Tramadol Dependence: A Case Series from India , 2012, Indian journal of psychological medicine.

[9]  R. Boostani,et al.  Tramadol induced seizure: A 3-year study. , 2012, Caspian journal of internal medicine.

[10]  J. Dorabjee,et al.  Opioid substitution therapy in resource-poor settings. , 2011, Bulletin of the World Health Organization.

[11]  Heino Stöver.  Barriers to Opioid Substitution Treatment Access, Entry and Retention: A Survey of Opioid Users, Patients in Treatment, and Treating and Non-Treating Physicians , 2010, European Addiction Research.

[12]  G. Bigelow,et al.  Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. , 2010, Drug and alcohol dependence.

[13]  R. Ali,et al.  Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. , 2008, Addiction.

[14]  Jaehak Yu,et al.  Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study. , 2006, The American journal on addictions.

[15]  W. Ling,et al.  Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. , 1994, Journal of psychoactive drugs.